Syneos Health, Inc. Class A Common Stock Underwriting AgreementUnderwriting Agreement • August 8th, 2018 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledAugust 8th, 2018 Company Industry JurisdictionThe stockholders named in Schedule II hereto (the “Selling Stockholders”) of Syneos Health, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Morgan Stanley & Co. LLC as set forth in Schedule I hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof, and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis) an aggregate of 6,000,000 shares (the “Shares”) of Class A Common Stock, par value $0.01 (“Stock”) of the Company.